Group I (n = 2099) | Group II (n = 3647) | Group III (n = 1600) | Group IV (n = 210) | Group V (n = 123) | P value | |
---|---|---|---|---|---|---|
Age, years | 54 ± 11 | 63 ± 12 | 71 ± 11 | 73 ± 11 | 66 ± 13 | <0.001 |
Male | 1745(83.1) | 2763(75.8) | 970(60.6) | 95(45.2) | 79(64.2) | <0.001 |
BMI, kg/m2 | 24 ± 3 | 24 ± 3 | 24 ± 3 | 23 ± 3 | 24 ± 3 | 0.284 |
Past History | ||||||
Hypertension | 739(35.3) | 1571(43.2) | 953(59.8) | 156(74.6) | 75(61.5) | <0.001 |
DM | 445(21.3) | 789(21.7) | 505(31.7) | 99(47.6) | 60(48.8) | <0.001 |
Previous IHD | 190(9.1) | 420(11.6) | 239(15.1) | 39(18.8) | 29(23.6) | <0.001 |
Hyperlipidemia | 184(8.8) | 273(7.5) | 121(7.6) | 17(8.1) | 8(6.6) | 0.171 |
Smoking | 1276(61.1) | 1779(49.1) | 493(31.2) | 53(25.9) | 39(32.2) | <0.001 |
At admission | ||||||
SBP (mmHg) | 130 ± 26 | 127 ± 28 | 117 ± 33 | 111 ± 36 | 123 ± 35 | <0.001 |
DBP (mmHg) | 81 ± 16 | 78 ± 17 | 72 ± 19 | 70 ± 23 | 75 ± 21 | <0.001 |
Killip class | 1.3 ± 0.7 | 1.4 ± 0.8 | 1.8 ± 1.1 | 2.1 ± 1.2 | 2.0 ± 1.2 | <0.001 |
LVEF (%) | 52 ± 11 | 51 ± 12 | 48 ± 13 | 47 ± 14 | 47 ± 12 | <0.001 |
Biochemical parameters | ||||||
Creatinine (mg/dL) | 0.8 ± 0.1 | 1.0 ± 0.2 | 1.4 ± 0.3 | 2.3 ± 0.5 | 9.5 ± 8.9 | <0.001 |
Troponin-I (ng/mL) | 40(9,79) | 30(7,68) | 28(5,73) | 31(10,56) | 28(6,51) | 0.007 |
CK-MB (U/L) | 133(38,277) | 132(40,283) | 112(26,243) | 84(27,195) | 69(20,176) | <0.001 |
TC (mg/dL) | 188 ± 44 | 183 ± 43 | 175 ± 45 | 165 ± 42 | 174 ± 60 | 0.004 |
LDL (mg/dL) | 122 ± 42 | 116 ± 42 | 112 ± 41 | 100 ± 39 | 106 ± 52 | 0.026 |
TG (mg/dL) | 109(72,163) | 98(66,143) | 95(66,140) | 105(74,152) | 91(66,150) | <0.001 |
Glucose (mg/dL) | 161 ± 66 | 168 ± 70 | 201 ± 100 | 234 ± 134 | 201 ± 106 | <0.001 |
hs-CRP (mg/dL) | 0.6(0.2,3.4) | 0.8(0.2,4.2) | 1.3(0.3,7.0) | 4.6(0.8,15.0) | 2.1(0.6,9.8) | <0.001 |
NT-proBNP (pg/mL) | 223 (57,871) | 346 (75,1414) | 1144 (230,3973) | 5423 (1296,21374) | 21191 (4957,35000) | <0.001 |